Perceptive Capital Solutions Corp. (PCSC) rose 20.19%, climbing $2.16 to $12.86, after the company announced a business combination agreement with Freenome, aiming to create a publicly listed company focused on AI-enabled multi-omics blood-based multi-cancer detection.
The planned merger brings together Perceptive's capital platform with Freenome's cutting-edge AI/ML-driven cancer detection technology, a move seen as transformative in the early detection and diagnostics space. The deal raised investor optimism about the future commercial and clinical potential of a merged entity.
On the day of the announcement, PCSC experienced unusually heavy trading volume as markets reacted to the merger news. The stock's 52-week range is approximately $4.10 - $15.20.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.